These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

267 related items for PubMed ID: 21198445

  • 1. CERAD-neuropsychological battery in screening mild Alzheimer's disease.
    Sotaniemi M, Pulliainen V, Hokkanen L, Pirttilä T, Hallikainen I, Soininen H, Hänninen T.
    Acta Neurol Scand; 2012 Jan; 125(1):16-23. PubMed ID: 21198445
    [Abstract] [Full Text] [Related]

  • 2. CERAD neuropsychological compound scores are accurate in detecting prodromal alzheimer's disease: a prospective AddNeuroMed study.
    Paajanen T, Hänninen T, Tunnard C, Hallikainen M, Mecocci P, Sobow T, Tsolaki M, Vellas B, Lovestone S, Soininen H.
    J Alzheimers Dis; 2014 Jan; 39(3):679-90. PubMed ID: 24246420
    [Abstract] [Full Text] [Related]

  • 3. CERAD test performances in amnestic mild cognitive impairment and Alzheimer's disease.
    Karrasch M, Sinervä E, Grönholm P, Rinne J, Laine M.
    Acta Neurol Scand; 2005 Mar; 111(3):172-9. PubMed ID: 15691286
    [Abstract] [Full Text] [Related]

  • 4. The CERAD Neuropsychological Battery in Patients with Idiopathic Normal Pressure Hydrocephalus Compared with Normal Population and Patients with Mild Alzheimer's Disease.
    Nerg O, Junkkari A, Hallikainen I, Rauramaa T, Luikku A, Hiltunen M, Jääskeläinen JE, Leinonen V, Hänninen T, Koivisto A.
    J Alzheimers Dis; 2021 Mar; 81(3):1117-1130. PubMed ID: 33896842
    [Abstract] [Full Text] [Related]

  • 5. Characteristics of Mild Cognitive Impairment Using the Thai Version of the Consortium to Establish a Registry for Alzheimer's Disease Tests: A Multivariate and Machine Learning Study.
    Tunvirachaisakul C, Supasitthumrong T, Tangwongchai S, Hemrunroj S, Chuchuen P, Tawankanjanachot I, Likitchareon Y, Phanthumchinda K, Sriswasdi S, Maes M.
    Dement Geriatr Cogn Disord; 2018 Mar; 45(1-2):38-48. PubMed ID: 29617684
    [Abstract] [Full Text] [Related]

  • 6. CERAD neuropsychological battery total score in multinational mild cognitive impairment and control populations: the AddNeuroMed study.
    Paajanen T, Hänninen T, Tunnard C, Mecocci P, Sobow T, Tsolaki M, Vellas B, Lovestone S, Soininen H, Addneuromed Consortium.
    J Alzheimers Dis; 2010 Mar; 22(4):1089-97. PubMed ID: 20930314
    [Abstract] [Full Text] [Related]

  • 7. [Mild cognitive impairment and Alzheimer's disease: an investigation of the CERAD-NP test battery].
    Barth S, Schönknecht P, Pantel J, Schröder J.
    Fortschr Neurol Psychiatr; 2005 Oct; 73(10):568-76. PubMed ID: 16217697
    [Abstract] [Full Text] [Related]

  • 8. Diagnostic accuracy of CERAD total score in a Colombian cohort with mild cognitive impairment and Alzheimer's disease affected by E280A mutation on presenilin-1 gene.
    Aguirre-Acevedo DC, Jaimes-Barragán F, Henao E, Tirado V, Muñoz C, Reiman EM, Tariot PN, Langbaum JB, Lopera F.
    Int Psychogeriatr; 2016 Mar; 28(3):503-10. PubMed ID: 26478578
    [Abstract] [Full Text] [Related]

  • 9. Progression of Alzheimer's disease during a three-year follow-up using the CERAD-NB total score: Kuopio ALSOVA study.
    Hallikainen I, Hänninen T, Fraunberg M, Hongisto K, Välimäki T, Hiltunen A, Karppi P, Sivenius J, Soininen H, Koivisto AM, ALSOVA study group.
    Int Psychogeriatr; 2013 Aug; 25(8):1335-44. PubMed ID: 23676340
    [Abstract] [Full Text] [Related]

  • 10. CERAD test performance and cognitive impairment in Parkinson's disease.
    Karrasch M, Laatu S, Martikainen K, Marttila R.
    Acta Neurol Scand; 2013 Dec; 128(6):409-13. PubMed ID: 23668316
    [Abstract] [Full Text] [Related]

  • 11. Diagnostic value of digital clock drawing test in comparison with CERAD neuropsychological battery total score for discrimination of patients in the early course of Alzheimer's disease from healthy individuals.
    Müller S, Herde L, Preische O, Zeller A, Heymann P, Robens S, Elbing U, Laske C.
    Sci Rep; 2019 Mar 05; 9(1):3543. PubMed ID: 30837580
    [Abstract] [Full Text] [Related]

  • 12. Applicability of the CANTAB-PAL computerized memory test in identifying amnestic mild cognitive impairment and Alzheimer's disease.
    Junkkila J, Oja S, Laine M, Karrasch M.
    Dement Geriatr Cogn Disord; 2012 Mar 05; 34(2):83-9. PubMed ID: 22922741
    [Abstract] [Full Text] [Related]

  • 13. The assessment of changes in cognitive functioning: age-, education-, and gender-specific reliable change indices for older adults tested on the CERAD-NP battery: results of the German Study on Ageing, Cognition, and Dementia in Primary Care Patients (AgeCoDe).
    Stein J, Luppa M, Luck T, Maier W, Wagner M, Daerr M, van den Bussche H, Zimmermann T, Köhler M, Bickel H, Mösch E, Weyerer S, Kaufeler T, Pentzek M, Wiese B, Wollny A, König HH, Riedel-Heller SG.
    Am J Geriatr Psychiatry; 2012 Jan 05; 20(1):84-97. PubMed ID: 22183013
    [Abstract] [Full Text] [Related]

  • 14. Education-Based Cutoffs for Cognitive Screening of Alzheimer's Disease.
    Alenius M, Ngandu T, Koskinen S, Hallikainen I, Hänninen T, Karrasch M, Kivipelto M, Raivio MM, Laakkonen ML, Krüger J, Suhonen NM, Hokkanen L.
    Dement Geriatr Cogn Disord; 2022 Jan 05; 51(1):42-55. PubMed ID: 35196653
    [Abstract] [Full Text] [Related]

  • 15. Comparison of verbal episodic memory measures: consortium to establish a registry for Alzheimer's disease--Neuropsychological Assessment Battery (CERAD-NAB) versus California Verbal Learning Test (CVLT).
    Beck IR, Gagneux-Zurbriggen A, Berres M, Taylor KI, Monsch AU.
    Arch Clin Neuropsychol; 2012 Aug 05; 27(5):510-9. PubMed ID: 22718104
    [Abstract] [Full Text] [Related]

  • 16. A total score for the CERAD neuropsychological battery.
    Chandler MJ, Lacritz LH, Hynan LS, Barnard HD, Allen G, Deschner M, Weiner MF, Cullum CM.
    Neurology; 2005 Jul 12; 65(1):102-6. PubMed ID: 16009893
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Attention and CERAD test performances in cognitively impaired elderly subjects.
    Verhülsdonk S, Hellen F, Höft B, Supprian T, Lange-Asschenfeldt C.
    Acta Neurol Scand; 2015 Jun 12; 131(6):364-71. PubMed ID: 25352352
    [Abstract] [Full Text] [Related]

  • 19. Effects of age, education and gender in the Consortium to Establish a Registry for the Alzheimer's Disease (CERAD)-Neuropsychological Assessment Battery for Cantonese-speaking Chinese elders.
    Liu KP, Kuo MC, Tang KC, Chau AW, Ho IH, Kwok MP, Chan WC, Choi RH, Lam NC, Chu MM, Chu LW.
    Int Psychogeriatr; 2011 Dec 12; 23(10):1575-81. PubMed ID: 21729408
    [Abstract] [Full Text] [Related]

  • 20. Can the CERAD neuropsychological battery be used to assess cognitive impairment in Parkinson's disease?
    Camargo CHF, Bronzini A, Tolentino ES, Medyk C, Schultz-Pereira GL.
    Arq Neuropsiquiatr; 2018 Mar 12; 76(3):145-149. PubMed ID: 29809231
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.